Docket Number:28A-981221
Inventor:Chung-Hsuan Chen, Wei-Chao Chang, Michael Hsiao, Ming-Shyan Huang, Chih-Jen Yang
IP Status:US 9,321,818
Abstract:
Methods for diagnosis of non-small cell lung cancers by detection of endogenous peptides in exhaled breath condensate are provided. Diagnostic peptides derived from dermcidin are provided. A specific dermcidin-derived peptide E-R11, having the sequence ENAGEDPGLAR, is provided. E-R11 peptide levels in EBC, as measured by mass spectrometry, are highly diagnostic of non-small cell lung cancers.
Fields of Application:
Diagnosis of non-small cell lung cancers
Advantages when compared to the existing technologies:
Methods for diagnosis of non-small cell lung cancers by exhaled breath condensate are provided.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
